Difficulty: Medium
Average Score: 83%
Practice
A patient suffering status asthmatics presents in the emergency department. Even large parenteral doses of a selective $B_2$ agonist fail to dilate the airways adequately; rather, they cause dangerous degrees of tachycardia. Which of the following pharmacologic interventions or approaches is most likely to control the acute symptoms and restore the bronchodilator efficacy of the adrenergic drug?
Correct answer
B
Rationale
The correct answer is B) Give a parenteral corticosteroid.
In status asthmaticus, which is a severe and life-threatening asthma attack, the airways are extremely inflamed and constricted. Selective $B_2$ agonists like albuterol may not be effective in this situation due to the overwhelming inflammation. Corticosteroids, such as methylprednisolone or prednisone, are potent anti-inflammatory agents that can help reduce airway inflammation, making it easier for the $B_2$ agonist to work effectively.
Option A) Add inhaled cromolyn is incorrect because cromolyn is a mast cell stabilizer that is more effective in preventing asthma symptoms rather than treating acute exacerbations like status asthmaticus.
Option C) Give parenteral diphenhydramine is incorrect as diphenhydramine is an antihistamine that can help with allergic reactions but does not address the underlying inflammation seen in status asthmaticus.
Option D) Switch to epinephrine is incorrect because while epinephrine is a non-selective adrenergic agonist that can help dilate the airways, it can also lead to significant side effects like increased heart rate and blood pressure, which can be dangerous in this scenario.
In an educational context, understanding the rationale behind choosing corticosteroids in severe asthma exacerbations is crucial for healthcare providers managing patients with acute respiratory distress. It highlights the importance of addressing airway inflammation in addition to bronchodilation for effective management of severe asthma attacks.
In status asthmaticus, which is a severe and life-threatening asthma attack, the airways are extremely inflamed and constricted. Selective $B_2$ agonists like albuterol may not be effective in this situation due to the overwhelming inflammation. Corticosteroids, such as methylprednisolone or prednisone, are potent anti-inflammatory agents that can help reduce airway inflammation, making it easier for the $B_2$ agonist to work effectively.
Option A) Add inhaled cromolyn is incorrect because cromolyn is a mast cell stabilizer that is more effective in preventing asthma symptoms rather than treating acute exacerbations like status asthmaticus.
Option C) Give parenteral diphenhydramine is incorrect as diphenhydramine is an antihistamine that can help with allergic reactions but does not address the underlying inflammation seen in status asthmaticus.
Option D) Switch to epinephrine is incorrect because while epinephrine is a non-selective adrenergic agonist that can help dilate the airways, it can also lead to significant side effects like increased heart rate and blood pressure, which can be dangerous in this scenario.
In an educational context, understanding the rationale behind choosing corticosteroids in severe asthma exacerbations is crucial for healthcare providers managing patients with acute respiratory distress. It highlights the importance of addressing airway inflammation in addition to bronchodilation for effective management of severe asthma attacks.